Prelude Capital Management’s Endocyte, Inc. Common Stock ECYT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-44,284
| Closed | -$786K | – | 1944 |
|
|
2018
Q3 | $786K | Sell |
44,284
-7,969
| -15% | -$141K | 0.05% | 268 |
|
|
2018
Q2 | $721K | Sell |
52,253
-353
| -0.7% | -$4.87K | 0.05% | 312 |
|
|
2018
Q1 | $478K | Buy |
52,606
+9,948
| +23% | +$90.4K | 0.03% | 396 |
|
|
2017
Q4 | $183K | Buy |
42,658
+42,058
| +7,010% | +$180K | 0.01% | 559 |
|
|
2017
Q3 | $1K | Sell |
600
-700
| -54% | -$1.17K | ﹤0.01% | 1444 |
|
|
2017
Q2 | $2K | Sell |
1,300
-10,900
| -89% | -$16.8K | ﹤0.01% | 1415 |
|
|
2017
Q1 | $31K | Buy |
+12,200
| New | +$31K | ﹤0.01% | 1122 |
|
|
2015
Q2 | – | Sell |
-7,900
| Closed | -$49K | – | 2120 |
|
|
2015
Q1 | $49K | Buy |
+7,900
| New | +$49K | 0.01% | 1242 |
|
|
2014
Q4 | – | Sell |
-16,326
| Closed | -$99K | – | 2165 |
|
|
2014
Q3 | $99K | Sell |
16,326
-1,774
| -10% | -$10.8K | 0.01% | 1011 |
|
|
2014
Q2 | $119K | Buy |
18,100
+13,655
| +307% | +$89.8K | 0.02% | 918 |
|
|
2014
Q1 | $106K | Buy |
+4,445
| New | +$106K | 0.01% | 883 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 1923 |
|